Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

PubWeight™: 12.31‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 18757870)

Published in Eur Heart J on August 30, 2008

Authors

Adam Torbicki1, Arnaud Perrier, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno Galiè, Piotr Pruszczyk, Frank Bengel, Adrian J B Brady, Daniel Ferreira, Uwe Janssens, Walter Klepetko, Eckhard Mayer, Martine Remy-Jardin, Jean-Pierre Bassand, ESC Committee for Practice Guidelines (CPG)

Author Affiliations

1: Department of Chest Medicine, Institute for Tuberculosis and Lung Diseases, Warsaw, Poland. a.torbicki@igichp.edu.pl

Associated clinical trials:

Diuretic Versus Placebo in Pulmonary Embolism (DiPER) | NCT02268903

Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein | NCT02430207

Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism (TELOS) | NCT01908231

Venous Thromboembolism in Myotonic Dystrophy Type 1 (DM1-VTE) | NCT03424460

Articles citing this

(truncated to the top 100)

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ (2013) 8.12

Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department. Radiology (2011) 2.47

Is a complete blood cell count useful in determining the prognosis of pulmonary embolism? Wien Klin Wochenschr (2014) 2.19

Evaluation of pulmonary embolism in the emergency department and consistency with a national quality measure: quantifying the opportunity for improvement. Arch Intern Med (2012) 2.15

The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int (2010) 1.96

Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest (2009) 1.94

Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol (2013) 1.71

Dual Energy CT Pulmonary Angiography with 6g Iodine-A Propensity Score-Matched Study. PLoS One (2016) 1.38

EANM guidelines for ventilation/perfusion scintigraphy : Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging (2009) 1.37

Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest (2010) 1.18

Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol (2013) 1.12

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J (2014) 1.12

Acute ECG ST-segment elevation mimicking myocardial infarction in a patient with pulmonary embolism. Cardiovasc Ultrasound (2010) 1.09

The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options. Curr Cardiol Rev (2010) 1.06

Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography. Acad Emerg Med (2012) 1.04

The role of ST-segment elevation in lead aVR in the risk assessment of patients with acute pulmonary embolism. Clin Res Cardiol (2011) 1.01

MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med (2011) 1.01

Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography. Radiology (2012) 1.00

Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study. Crit Care (2013) 0.98

The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care (2011) 0.98

An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine. Chest (2014) 0.98

Aggressive approach to pulmonary embolectomy for massive acute pulmonary embolism: a historical and contemporary perspective. Mayo Clin Proc (2010) 0.97

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I). J Transl Med (2011) 0.97

Clinical update on pulmonary embolism. Arch Med Sci (2013) 0.96

Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre. Kardiochir Torakochirurgia Pol (2015) 0.95

Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95

Embolectomy for acute pulmonary thromboembolism: from Trendelenburg's procedure to the contemporary surgical approach. Surg Today (2010) 0.94

The use of decision support to measure documented adherence to a national imaging quality measure. Acad Radiol (2014) 0.93

Management dilemmas in acute pulmonary embolism. Thorax (2013) 0.93

Focused critical care echocardiography. Crit Care Med (2013) 0.93

Values of the Wells and revised Geneva scores combined with D-dimer in diagnosing elderly pulmonary embolism patients. Chin Med J (Engl) (2015) 0.93

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J (2010) 0.92

Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers. Vasc Health Risk Manag (2009) 0.91

"I can't find anything wrong: it must be a pulmonary embolism": Diagnosing suspected pulmonary embolism in primary care, a qualitative study. PLoS One (2014) 0.91

Impact of rescue-thrombolysis during cardiopulmonary resuscitation in patients with pulmonary embolism. PLoS One (2009) 0.90

Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Thromb Res (2012) 0.90

Treatment of acute pulmonary embolism: update on newer pharmacologic and interventional strategies. Biomed Res Int (2014) 0.89

Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial. Respir Res (2009) 0.89

Impending paradoxical thromboembolism: thrombus caught in transit. A case report. Clin Res Cardiol (2012) 0.89

Treatment and secondary prevention of venous thromboembolism in cancer. Br J Cancer (2010) 0.88

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile. Eur J Clin Pharmacol (2012) 0.88

Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS One (2014) 0.88

D-dimer threshold increase with pretest probability unlikely for pulmonary embolism to decrease unnecessary computerized tomographic pulmonary angiography. J Thromb Haemost (2012) 0.87

Capnometry in suspected pulmonary embolism with positive D-dimer in the field. Crit Care (2009) 0.87

Life-saving systemic thrombolysis in a patient with massive pulmonary embolism and a recent hemorrhagic cerebrovascular accident. Tex Heart Inst J (2014) 0.87

Thrombolysis for massive pulmonary embolism in pregnancy: a case report. Int J Emerg Med (2011) 0.87

Dual energy CT pulmonary blood volume assessment in acute pulmonary embolism - correlation with D-dimer level, right heart strain and clinical outcome. Eur Radiol (2011) 0.86

Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication. Maedica (Buchar) (2013) 0.86

An unusual case of pulmonary embolism. J Surg Case Rep (2015) 0.86

Cardiac troponin I for predicting right ventricular dysfunction and intermediate risk in patients with normotensive pulmonary embolism. Neth Heart J (2015) 0.85

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit (2011) 0.85

Acute pulmonary embolism. Part 1: epidemiology and diagnosis. Nat Rev Cardiol (2010) 0.85

CT pulmonary angiography: increasingly diagnosing less severe pulmonary emboli. PLoS One (2013) 0.85

Pulmonary embolism in intensive care unit: Predictive factors, clinical manifestations and outcome. Ann Thorac Med (2010) 0.85

Predictive value of high-sensitivity troponin I and D-dimer assays for adverse outcome in patients with acute pulmonary embolism. Exp Ther Med (2012) 0.85

Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study. J Am Heart Assoc (2014) 0.84

Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist. Thromb J (2015) 0.84

Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications. Drugs (2014) 0.83

Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism. Multidiscip Respir Med (2013) 0.83

Immediate versus delayed integrated point-of-care-ultrasonography to manage acute dyspnea in the emergency department. Crit Ultrasound J (2014) 0.83

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report. Int J Gen Med (2011) 0.83

The geko™ electro-stimulation device for venous thromboembolism prophylaxis: a NICE medical technology guidance. Appl Health Econ Health Policy (2015) 0.83

Thrombus entrapped by patent foramen ovale in a patient with pulmonary embolism: a case report. Korean J Anesthesiol (2015) 0.83

Catheter-Directed Therapy in Acute Pulmonary Embolism with Right Ventricular Dysfunction: A Promising Modality to Provide Early Hemodynamic Recovery. Med Sci Monit (2016) 0.83

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation. Trials (2012) 0.83

Prothrombotic state in senile patients with acute exacerbations of chronic obstructive pulmonary disease combined with respiratory failure. Exp Ther Med (2013) 0.83

Detection of acute pulmonary embolism: feasibility of diagnostic accuracy of MRI using a stepwise protocol. Emerg Radiol (2013) 0.83

Respiratory review of 2013: pulmonary thromboembolism. Tuberc Respir Dis (Seoul) (2013) 0.82

The emperor's new clothes: hypersensitivity of the new cardiac isoenzymes. J Community Hosp Intern Med Perspect (2013) 0.82

Evaluation of right ventricular systolic function by the analysis of tricuspid annular motion in patients with acute pulmonary embolism. J Cardiovasc Ultrasound (2012) 0.82

Emergent pulmonary embolectomy and advanced glioblastoma multiforme. Case Rep Med (2010) 0.82

Simultaneously diagnosed pulmonary thromboembolism and hemopericardium in a man with thoracic spinal cord injury. J Spinal Cord Med (2012) 0.82

Impact of advanced age on the severity of normotensive pulmonary embolism. Heart Vessels (2014) 0.82

Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol (2013) 0.81

Acute lung failure. Semin Respir Crit Care Med (2011) 0.81

Rivaroxaban for the treatment of pulmonary embolism. Adv Ther (2013) 0.81

Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism. Thromb J (2014) 0.81

Dose and image quality at CT pulmonary angiography-comparison of first and second generation dual-energy CT and 64-slice CT. Eur Radiol (2011) 0.81

Computed tomography for the detection of free-floating thrombi in the right heart in acute pulmonary embolism. Eur Radiol (2010) 0.81

Computer-assisted detection of pulmonary embolism: evaluation of pulmonary CT angiograms performed in an on-call setting. Eur Radiol (2009) 0.81

Acute pulmonary embolism after pneumonectomy. J Thorac Dis (2012) 0.81

Comparison of computed tomography pulmonary angiography and point-of-care tests for pulmonary thromboembolism diagnosis in dogs. J Small Anim Pract (2014) 0.81

A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol (2012) 0.81

Prolonged chest compressions during cardiopulmonary resuscitation for in-hospital cardiac arrest due to acute pulmonary embolism. Tex Heart Inst J (2015) 0.81

Fluctuation of serum sodium and its impact on short and long-term mortality following acute pulmonary embolism. PLoS One (2013) 0.80

Imaging of acute pulmonary embolism. Emerg Radiol (2012) 0.80

A comparison of different techniques of two-dimensional speckle-tracking strain measurements of right ventricular systolic function in patients with acute pulmonary embolism. J Cardiovasc Ultrasound (2014) 0.80

Thrombolysis during cardiopulmonary resuscitation should be addressed in guidelines for pulmonary embolism. Eur Heart J (2008) 0.80

Right heart free-floating thrombus after leg injury. BMJ Case Rep (2012) 0.80

Surgical embolectomy for acute massive pulmonary embolism. Int J Clin Exp Med (2014) 0.80

Pulmonary embolism, part II: Management. Exp Clin Cardiol (2013) 0.80

Mycoplasma pneumonia combined with pulmonary infarction in a child. Int J Clin Exp Med (2015) 0.80

Fatal pulmonary embolism and coincidental cerebral infarction after spinal anesthesia -A case report-. Korean J Anesthesiol (2011) 0.80

Echocardiographic diagnosis, management and monitoring of pulmonary embolism with right heart thrombus in a patient with myotonic dystrophy: a case report. Cardiovasc Ultrasound (2010) 0.80

Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014. Clin Res Cardiol (2015) 0.79

Feasibility of computed tomography pulmonary angiography with low flow rates. J Clin Imaging Sci (2012) 0.79

Timing of discharge follow-up for acute pulmonary embolism: retrospective cohort study. West J Emerg Med (2015) 0.79

The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res (2012) 0.79

Sudden unexpected death in a patient with tumour associated pulmonary embolism. Case Rep Med (2014) 0.79

Articles by these authors

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J (2009) 14.06

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J (2012) 13.74

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J (2011) 13.10

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J (2012) 12.36

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J (2008) 12.32

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86

Universal definition of myocardial infarction. Circulation (2007) 11.69

Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64

Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med (2010) 9.92

Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2008) 8.20

Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98

Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail (2008) 6.80

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J (2010) 6.45

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32

Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet (2011) 6.25

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 6.17

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med (2010) 6.05

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96

Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol (2005) 5.88

Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA (2006) 5.74

Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med (2013) 5.60

Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet (2010) 5.30

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J (2015) 5.24

Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med (2013) 5.22

Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med (2013) 4.98

Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83

Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72

A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med (2009) 4.27

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med (2002) 3.91

Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90

Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med (2006) 3.70

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67

Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med (2006) 3.51

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50

Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J (2004) 3.45

A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg (2014) 3.43

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36

Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet (2008) 3.33

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ (2011) 3.28

Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res (2007) 3.28

The influence of acute pulmonary embolism on early and delayed prognosis for patients with chronic heart failure. Cardiol J (2012) 3.19

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med (2008) 3.13

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01

Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J (2007) 2.92

Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation (2004) 2.69

Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke (2007) 2.60

Chronic thromboembolic pulmonary hypertension. Circulation (2006) 2.58

Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.57

Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation (2007) 2.54

Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J (2010) 2.52

Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell (2011) 2.51

Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest (2006) 2.43

Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med (2002) 2.37

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J (2010) 2.36

Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J (2005) 2.34

Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol (2008) 2.33

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation (2004) 2.30

A computerized handheld decision-support system to improve pulmonary embolism diagnosis: a randomized trial. Ann Intern Med (2009) 2.27

A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med (2006) 2.18

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma. J Thorac Oncol (2015) 2.17

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med (2002) 2.16

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol (2005) 2.14

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med (2007) 2.14

Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol (2003) 2.13

Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clin Pharmacokinet (2011) 2.09

Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Transplantation (2013) 2.07

Lobar lung transplantation--is it comparable with standard lung transplantation? Transpl Int (2014) 2.05

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Chest (2012) 2.03

Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr (2004) 2.03

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology (2012) 2.02

Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol (2003) 2.01

Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J (2010) 2.01

A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience. J Thorac Oncol (2015) 1.99

Should a cardioverter-defibrillator be implanted in an Andersen-Tawil syndrome patient with severe ventricular arrhythmias and syncope? Kardiol Pol (2014) 1.99

Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest (2006) 1.99

Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ (2010) 1.99

Correlation between clinical parameters of periodontal disease and mean platelet volume in patients with coronary artery disease: a pilot study. Kardiol Pol (2013) 1.98